You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 14, 2024

UROCIT-K Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Urocit-k patents expire, and when can generic versions of Urocit-k launch?

Urocit-k is a drug marketed by Mission Pharma and is included in one NDA.

The generic ingredient in UROCIT-K is potassium citrate. There are two hundred and forty drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Urocit-k

A generic version of UROCIT-K was approved as potassium citrate by RISING on June 9th, 2006.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for UROCIT-K?
  • What are the global sales for UROCIT-K?
  • What is Average Wholesale Price for UROCIT-K?
Summary for UROCIT-K
Drug patent expirations by year for UROCIT-K
Drug Prices for UROCIT-K

See drug prices for UROCIT-K

Recent Clinical Trials for UROCIT-K

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Texas Southwestern Medical CenterEarly Phase 1

See all UROCIT-K clinical trials

Pharmacology for UROCIT-K

US Patents and Regulatory Information for UROCIT-K

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma UROCIT-K potassium citrate TABLET, EXTENDED RELEASE;ORAL 019071-001 Aug 30, 1985 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mission Pharma UROCIT-K potassium citrate TABLET, EXTENDED RELEASE;ORAL 019071-002 Aug 31, 1992 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mission Pharma UROCIT-K potassium citrate TABLET, EXTENDED RELEASE;ORAL 019071-003 Dec 30, 2009 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.